MILPITAS, Calif.–(BUSINESS WIRE)–ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in-vivo …
By Mike May, PhD Recently, the France-based WIDGeT consortium emerged from a collaboration between Sanofi, WhiteLab Genomics, the TaRGeT Laboratory at …
MILPITAS, Calif.--(BUSINESS WIRE)--ASC Therapeutics, a privately-held biopharmaceutical company pioneering the development of transformative in-vivo …
The Australian Cell and Gene Catalyst, a collaboration between AusBiotech and Medicines Australia, recommends that the Medical Board of Australia …
CRISPR systems are powerful tools for genetic engineering, but they have their limitations. Now, scientists have discovered almost 200 new CRISPR …
The first-in-humans trial of a CRISPR-based cholesterol treatment has delivered promising results, with one participant in the small study …
The dominance of biologics in the oncology market is a result of their efficacy in treating rare solid tumours and the escalating demand for …
Shelly Fan in Singularity Hub: CRISPR-based therapies just hit another milestone. In a small clinical trial with 10 people genetically prone to …
Cell and gene therapies are the next frontier in medicine and promise long-sought hope for people living with incurable and fatal conditions. As …
The US Food and Drug Administration’s growing comfort with gene editing has sparked a more relaxed regulatory approach to the products. Gene editing …
• Updated data from over 60 patients showed consistent, deep and durable serum TTR reduction achieved with a single dose of NTLA-2001, including in 29 …
Four Chinese children who were born deaf are able to hear after participating in an experimental gene therapy. But it’s an expensive option. This …
Researchers have developed a new bioreactor that can manufacture T cells faster than other technologies, which may advance immunotherapy.
Genome editing methods generally involve two critical steps: targeting a DNA sequence of interest and introducing the desired genetic modification. …
PULLMAN, Wash. — A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy …